Settlement Amount: $4.8 Million (Confidential)
Injury Type: Fatal Vaso-Occlusive Crisis

Background

Kai, a vibrant 8-year-old from Houston, participated in Pfizer’s pediatric extension study (2023-2024). Despite initial “excellent response” notes, he died from a catastrophic VOC that triggered multi-organ failure.

Medical Tragedy

• Final 72 Hours:
  • ER initially sent him home with opioids
  • Readmitted with acute chest syndrome
  • Cardiac arrest during exchange transfusion
• Autopsy Findings:
  • Sickled cells clogged pulmonary vasculature
  • Brain damage from prolonged hypoxia

Legal Hurdles

1. Clinical trial waiver attempted to block lawsuits
2. Hospital destroyed some monitoring records
3. Statute of limitations complications

Injurease’s Response

• Hired clinical research ethics expert to challenge trial consent forms
• Reconstructed timeline using family’s smartphone photos/videos
• Filed in state court to avoid federal preemption defenses

Key Evidence

• Pfizer’s own safety officer had recommended trial suspension
• EMA inspection reports citing protocol violations
• Social media posts showing Pfizer reps celebrating enrollment numbers

Resolution

• $4.8M settlement with:
  • $3M to parents
  • $1.8M to sickle cell research foundation
• Legacy impact:
  • New FDA rules for pediatric trial monitoring
  • Hospital revised ER sickle cell protocols

Father’s Statement:
“Kai was treated like a lab rat, not a little boy. This settlement won’t bring him back, but it forces them to remember his name.”